Delivery Order SPE2DB24D6044-SPE2DB25FLJJS
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $8,659.05 for NOVOSEVEN RT 2 MG vials under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The award was made on September 19, 2025, with an ultimate completion date of October 10, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $27,604.30 order is for the supply of NOVOSEVEN RT 2 MG VIALS, a specialized pharmaceutical product. The delivery order is part of Amerisourcebergen's existing indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,846.64 firm fixed-price delivery order is for the supply of NovoSeven RT 2 mg vials, a specialty medication. This award is a part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOSEVEN RT 5 MG VIALS, a medication, with a ceiling value of $7,277.44 and a period of performance through June 18, 2025. The award is not set aside and is a firm fixed-price delivery order contract. Amerisourcebergen Drug Corp is the prime contractor and will be...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NOVOSEVEN RT 2 MG VIALS. The contract has a potential value of $21,675.92 and a performance completion date of January 12, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,900.96 Firm Fixed Price delivery order contract is for the supply of NovoSeven RT 5 mg vials, a specialty medication. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,760.43, is for the delivery of 4563398480 NOVOSeven RT 2 MG vials and has a completion date of February 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award, valued at $6,911.29, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of NovoSeven RT 5 mg vials, a pharmaceutical product. This award is a delivery order under a single-award Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This IDC...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,154,798 units of the pharmaceutical product NOVOSEVEN RT 5 MG VIALS. The firm fixed price contract has a potential value of $40,013.82 and a completion date of January 12, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contracts from DLA to supply...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,312,251 vials of the medication NovoSeven RT 2 mg. The $5,520.86 contract has a completion date of February 2, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously provided pharmaceuticals and medical supplies to support DLA Troop Support Medical programs. This delivery order does not have a...
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLJJSDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively-procured delivery order valued at approximately $51K for NOVOSEVEN RT 5 mg vials. The contract, issued by the Defense Logistics Agency under its Defense Supply Chain operations, carries a firm fixed price structure and is scheduled for completion by September 12, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical commodities to military and federal healthcare systems globally. No set-aside designation was applied to this award, reflecting the open competitive procurement process. NOVOSEVEN RT is a recombinant activated Factor VII indicated for hemostasis management in patients with hemophilia and other bleeding disorders, making this delivery order consistent with AmerisourceBergen's established role as a critical vendor for specialized pharmaceutical products supporting military medicine and the Defense Health Agency. The firm's extensive contract portfolio with DLA demonstrates its capability to manage high-volume pharmaceutical distribution across multiple therapeutic domains, including specialty medications, vaccines, and medical devices, to support federal medical supply requirements domestically and internationally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.0k | 8/21/25 |